Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott Applebaum currently holds 344,022 shares of MEDGENICS, INC. (MDGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Applebaum has been a net buyer of MDGN stock. They have purchased $25.0K and sold $0 worth of shares.
Scott Applebaum's most recent insider trade was on Feb 10, 2021, when they sold 21,178 shares at $2.85 per share.
Scott Applebaum serves as Executive at MEDGENICS, INC. (MDGN). They have executed 4 insider transactions totaling $25.0K over their tenure at the company.
Scott Applebaum holds the position of Executive at MEDGENICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Scott Applebaum has shown a buying trading pattern, with $25.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Scott Applebaum was on Feb 10, 2021, when they sold $60.4K worth of TRVN shares. This transaction involved 21,178 shares at $2.85 per share.
Scott Applebaum currently owns 344,022 shares of MEDGENICS, INC. (MDGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott Applebaum's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott Applebaum has 4 Form 4 filings on record as an insider at MEDGENICS, INC..
Set alerts for Scott Applebaum and 40,000+ other insiders.